Stay updated on Magrolimab in Hematological Malignancies Clinical Trial

Sign up to get notified when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Magrolimab in Hematological Malignancies Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Access to the study page now returns a 403 Forbidden error, replacing the expected study content. This indicates a permissions issue rather than an update to the study data or page features.
    Difference
    22%
    Check dated 2026-09-30T01:31:28.000Z thumbnail image
  2. Check
    16 days ago
    Change Detected
    Summary
    The page shows Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates a software version update applied to the page.
    Difference
    0.0%
    Check dated 2026-09-16T00:24:22.000Z thumbnail image
  3. Check
    23 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6. This signals a new release of the ClinicalTrials.gov interface/backend, and the visible study content remains unchanged.
    Difference
    0.0%
    Check dated 2026-09-01T19:47:10.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page now includes a line indicating 2017 U.S. NIH grant/contract funding in the study's information.
    Difference
    0.0%
    Check dated 2026-08-25T21:32:00.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page update adds new metadata and navigation references related to Gilead's clinical trials website, study documents, IPD planning, and publications, plus associated MeSH terms, enriching contextual references and external links for the Magrolimab study.
    Difference
    91%
    Check dated 2026-08-11T18:05:21.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Core study details and linked documents were removed, including intervention names, arms, and locations, along with several key study documents and metadata that described how the trial is organized and where it takes place.
    Difference
    20%
    Check dated 2026-08-04T15:18:25.000Z thumbnail image

Stay in the know with updates to Magrolimab in Hematological Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.